Vaccine provides an aid in control of disease associated with canine influenza virus H3N8
The Vanguard CIV H3N8 vaccine is part of the Zoetis family of CIRD vaccines. Vanguard CIV H3N8 vaccine is licensed for use in healthy dogs 8 weeks of age or older. It is recommended for dogs housed in communal facilities or that are in contact with other dogs in locations such as:
Directions: Vaccination of healthy dogs is recommended. Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs 8 weeks of age and older should receive 2 doses administered 3 weeks apart. Annual revaccination with a single dose is recommended.
1. Data on file, Study Report No. 3161R-60-09-383, Zoetis LLC. 2. Data on file, Study Report No. 3467R-60-06-291, Zoetis LLC.
Precautions: Store at 2°-7°C (35°-45°F). Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Contains gentamicin as preservative.
Technical inquiries should be directed to Zoetis Veterinary Services, (800) 366-5288 (USA), (800) 461-0917 (Canada).